Analysis on the registration and review system of emergency medical devices in China and abroad in the context of COVID-19

  • Yiming Xu
  • Mingyang Wu
  • Wei Chen
  • Siyi Ge
  • Yi Liang China Pharmaceutical University

Abstract

Objective


In the context of COVID-19, the domestic and foreign demand for emergency medical devices, such as medical masks and protective suits, is surging, and it is urgent to complete the registration and review of emergency medical devices with high efficiency and quality, which requires a mature and perfect registration and review system as the support. This paper aims to compare and analyze the domestic and foreign registration and review system of emergency medical device, summarize the good experience, and provide feasible suggestions for improving China's emergency medical device registration and review system.


Method


USA, Canada, Japan and the European Union were selected to make a comparative analysis with China from the aspects of legal system and emergency registration and review procedure by literature research, comparative analysis and other theoretical methods.


Results


The legal system and review mechanism of emergency medical device registration in China have been relatively perfect, but the safety and risk balance mechanism and the comprehensiveness of emergency management measures need to be further improved.


Conclusion


On the basis of maintaining its own institutional advantages, China should learn from foreign experience to further optimize the registration and review system of emergency medical devices, so as to improve the ability of response and implementation of China in public health emergencies.

Keywords: COVID-19, emergency medical devices, Center for Medical Device Evaluation (CMDE), National Medical Products Administration (NMPA), PAHPA, FDA, Emergency Use Authorization (EUA)

Downloads

Download data is not yet available.

References

1. Annual medical device registration work report in 2020 [Internet]. China: National Medical Products Administration (NMPA); 2021 Feb 05 [cited 2021 Oct 30]. Available from:
https://www.nmpa.gov.cn/yaowen/ypjgyw/20210205111730106.html
2. Issuance announcement of the emergency approval procedures for medical devices [Internet]. China: National Medical Products Administration (NMPA); 2021 Dec 05 [cited 2021 Oct 30]. Available from:
https://www.nmpa.gov.cn/ylqx/ylqxggtg/20211230171343118.html
3. Announcement of China's Regulatory Requirements and Standards for COVID-19 Detection Reagents and Protective Products [Internet]. China: National Medical Products Administration (NMPA); 2020 Mar 30 [cited 2021 Oct 30]. Available from:
https://www.nmpa.gov.cn/yaowen/ypjgyw/20200330170001581.html
4. Classification Catalogue of Medical Devices [Internet]. China: National Medical Products Administration (NMPA); 2021 Oct 20 [cited 2021 Oct 30]. Available from:
http://app1.nmpa.gov.cn/data_nmpa/face3/base.jsp?tableId=139&tableName=TABLE139&title=%D2%BD%C1%C6%C6%F7%D0%B5%B7%D6%C0%E0%C4%BF%C2%BC&bcId=154804104651613033739874139064&CbSlDlH0=qAc.rqqdHuZdHuZdH4frrjBdoyPk06HSzACkkKlTuSLqqkZ
5. Registration and Filing Guidance of Medical Devices [Internet]. China: State Administration for Market Regulation; 2021 Aug 26 [cited 2021 Oct 30]. Available from:
https://gkml.samr.gov.cn/nsjg/fgs/202108/t20210831_334228.html
6. Federal Food, Drug, and Cosmetic Act [Internet]. America: Department of Health and Human Services. 2013 Dec 16 [cited 2021 Oct 30].Available from:
https://www.law.cornell.edu/cfr/text/21/chapter-I/subchapter-D
7. Emergency Use Authorization of Medical Products and Related Authorities [Internet]. America: Food and Drug Administration (FDA); 2018 Oct 17 [cited 2021 Oct 30]. Available from:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities
8. Determination of Public Health Emergency [Internet]. America: Federal Register. 2020 Feb 04 [cited 2021 Oct 30]. Available from:
https://www.federalregister.gov/documents/2020/02/07/2020-02496/determination-of-public-health-emergency
9. Templates for EUA Submissions [Internet]. America: Food and Drug Administration (FDA); 2021 Oct 22 [cited 2021-10-30]. Available from:
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas
10. COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders [Internet]. America: Food and Drug Administration (FDA); 2021 Oct 07 [cited 2021-10-30]. Available from:
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-related-guidance-documents-industry-fda-staff-and-other-stakeholders
11. Food and Drugs Act (R.S.C., 1985, c. F-27) [Internet]. Canada: Government of Canada; 2021 May 06 [cited 2022 Jan 10]. Available from:
https://laws-lois.justice.gc.ca/eng/acts/f-27/page-5.html#h-234517
12. Medical Devices Regulations (SOR/98-282) [Internet]. Canada: Government of Canada; 2021 June 23 [cited 2022 Jan 10]. Available from:
https://laws.justice.gc.ca/eng/regulations/SOR-98-282/page-2.html
13. Interim order respecting the importation and sale of medical devices for use in relation to COVID-19 [Internet]. Canada: Health Canada; 2020 Mar 18 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/interim-order-importation-sale-medical-devices-covid-19.html
14. Interim Order No. 2 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 [Internet]. Canada: Health Canada; 2021 Mar 01 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/interim-order-2-import-sale-medical-devices.html
15. Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 [Internet]. Canada: Health Canada; 2022 Feb 21 [cited 2022 Apr 21]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/interim-order-3-import-sale-medical-devices.html
16. Medical devices for uses related to COVID-19-Expedited authorization pathways for COVID-19 medical devices [Internet]. Canada: Health Canada; 2021 Oct 05 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/about.html#_Expedited_authorization_pathways
17. Health Canada's special access programs: Request access to a medical device [Internet]. Canada: Health Canada; 2022 Oct 20 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/medical-devices.html
18. Applications for medical devices under the Interim Order for use in relation to COVID-19: Guidance document [Internet]. Canada: Health Canada; 2021 Aug 26 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/interim-order-importation-sale-medical-devices-covid-19/guidance-medical-device-applicatio ns.html
19. Testing devices for COVID-19: Overview-How to get authorization [Internet]. Canada: Health Canada; 2021 Dec 17 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing.html#a4
20. Medical Devices Directorate [Internet]. Canada: Health Canada; 2021 Sep 04 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/corporate/about-health-canada/branches-agencies/health-products-food-branch/medical-devices-directorate.html#a1
21. Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19 [Internet]. Canada: Health Canada; 2021 May 03 [cited 2022 Jan 10]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs.html
22. Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations: SOR/2022-18 [Internet]. Canada: Health Canada; 2022 Feb 11 [cited 2022 Apr 21]. Available from:
https://gazette.gc.ca/rp-pr/p2/2022/2022-03-02/html/sor-dors18-eng.html
23. Medical devices for COVID-19: Conducting a clinical trial [Internet]. Canada: Health Canada; 2022 Mar 02 [cited 2022 Apr 21]. Available from:
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/conducting-medical-device-trial.html#a2
24. Pharmaceuticals and Medical Devices Act [Internet]. Canada: Ministry of Health, Labour, and Welfare; 2014 Nov 25 [cited 2022 Jan 10]. Available from:
https://www.mhlw.go.jp/web/t_doc_keyword?keyword=%E5%8C%BB%E7%99%82%E6%A9%9F%E5%99%A8&dataId=81004000&dataType=0&pageNo=1&mode=0
25. Chief Executive’s Statement [Internet]. Japan: Pharmaceuticals and Medical Devices Agency (PMDA); 2020 Apr 10 [cited 2022 Jan 10]. Available from:
https://www.pmda.go.jp/english/about-pmda/outline/0010.html
26. Pharmaceuticals and Medical Devices Agency. Recognition review of pharmaceuticals, medical devices, in vitro diagnostic products, and regenerative medicine products related to the outbreak of coronavirus [Internet]. Japan: Pharmaceuticals and Medical Devices Agency (PMDA); 2020 Apr 13 [cited 2022 Jan 10]. Available from:
https://www.pmda.go.jp/files/000234904.pdf
27. Approval and review of pharmaceuticals, medical devices, in vitro diagnostic products, and regenerative medicine products related to the outbreak of coronavirus [Internet]. Japan: Pharmaceuticals and Medical Devices Agency (PMDA); 2020 May 12 [cited 2022 Jan 10]. Available from:
https://www.pmda.go.jp/files/000235010.pdf
28. Toward the Earlier Marketing of Innovative Medical Devices [Internet]. Japan: Pharmaceuticals and Medical Devices Agency (PMDA); 2021 May 24 [cited 2022 Jan 10]. Available from:
https://www.pmda.go.jp/english/about-pmda/0006.pdf
29. Commission Recommendation (EU) 2020/403 of 13 March 2020 on conformity assessment and market surveillance procedures within the context of the COVID-19 threat [Internet]. Europe: European Commission; 2020 Mar 13 [cited 2021 Oct 30]. Available from:
https://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1584654491688&uri=CELEX:32020H0403
30. Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context [Internet]. Europe: European Commission; 2020 Apr 03 [cited 2021 Oct 30]. Available from:
https://ec.europa.eu/health/sites/default/files/md_sector/docs/md_guidance-active-implantable_en.pdf
31. Sonderzulassung von Medizinprodukten [Internet]. Germany: Bundesinstitutfur Arzneimittel und Medizinprodukte; 2021 Oct 20 [cited 2021 Oct 30]. Available from:
https://www.bfarm.de/DE/Medizinprodukte/Aufgaben/Sonderzulassungen/_node.html
32. YAN Shu, CHEN Juan, OUYANG Zhaolian. Analysis on China and US Medical Device Emergency Approval Systems and Their Practical Application.China Medical Devices. 2021;36(07):120-124.
33. Regulations for the Supervision and Administration of Medical Devices [Internet]. China: National Medical Products Administration (NMPA); 2021 Mar 18 [cited 2022 Jan 10]. Available from:
https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20210318084145148.html
Statistics
159 Views | 211 Downloads
How to Cite
Xu, Y., M. Wu, W. Chen, S. Ge, and Y. Liang. “Analysis on the Registration and Review System of Emergency Medical Devices in China and Abroad in the Context of COVID-19”. International Journal of Drug Regulatory Affairs, Vol. 10, no. 2, June 2022, pp. 46-55, doi:10.22270/ijdra.v10i2.522.